CurrentRheuma
Get Weekly

Topic · page 15 of 40

Rheumatoid arthritis

Early and established rheumatoid arthritis in adults: diagnosis and prediction (clinically suspect arthralgia, people at risk), treat-to-target, conventional, biologic and targeted synthetic drugs, tapering and withdrawal, glucocorticoids, extra-articular disease and rheumatoid arthritis–associated interstitial lung disease

Briefs 561–600 of 1,564 placed here, newest publication first

Briefs in Rheumatoid arthritis

Newest publication first

  1. Semin Arthritis Rheum

    Rheumatoid arthritis and the risk of 90-day readmission after hospitalization for heart failure

    Cohort study

  2. Arthritis Res Ther

    Achievement of treatment targets and maintenance of response with upadacitinib in patients with moderate-to-severe rheumatoid arthritis in real-world practice: 1-year outcomes from the UPHOLD observational study

    Cohort study

  3. Semin Arthritis Rheum

    Risk of major adverse cardiovascular events following targeted therapy in patients with rheumatoid arthritis: a real-world analysis stratified by cardiovascular risk

    Cohort study

  4. Semin Arthritis Rheum

    Determinants of health-related quality of life in adults living with rheumatoid arthritis: a systematic review

    Meta-analysis

  5. Arthritis Rheumatol

    Peripheral Biomarker Signatures in Rheumatoid Arthritis–Associated Interstitial Lung Disease

    Cross-sectional study

  6. Arthritis Res Ther

    Methotrexate-related drug reactions on kidneys and liver in rheumatoid arthritis: an analysis of spontaneous reports in EudraVigilance

    Cohort study

  7. Arthritis Res Ther

    Discontinuation vs. continuation of concomitant methotrexate in patients with rheumatoid arthritis on certolizumab pegol: results from a randomised, controlled trial

    Randomized controlled trial

  8. RMD Open

    Influence of body mass index on cardiovascular risk in rheumatoid arthritis varies across anti-citrullinated protein antibody status and biologic use

    Cohort study

  9. Joint Bone Spine

    Risk of cancer in patients with rheumatoid arthritis under tocilizumab: Data from the French national registry REGATE

    Cohort study

  10. Ann Rheum Dis

    Treatment with methotrexate plus oral prednisolone versus triple therapy (methotrexate/sulfasalazine/hydroxychloroquine) plus intra-articular glucocorticoids in early rheumatoid arthritis: a prespecified nonrandomised subgroup analysis of clinical and radiographic data at 48 weeks from the NORD-STAR trial's conventional treatment arm

    Secondary analysis

  11. Rheumatology (Oxford)

    Dual-energy CT for evaluating bone marrow oedema in RA: an observational single-center study

    Diagnostic or prognostic study

  12. RMD Open

    Patient-reported outcomes as early warning signs of flare following drug cessation in rheumatoid arthritis

    Cohort study

  13. J Rheumatol

    Rural-Dwelling Patients With Rheumatoid Arthritis and Risk of Myocardial Infarction Hospitalization: An Observational Study Using the National Inpatient Sample

    Cross-sectional study

  14. Clin Exp Rheumatol

    Does different administration method of methotrexate matter in early rheumatoid arthritis? An exploratory register-based study

    Cohort study

  15. Clin Exp Rheumatol

    Interaction of HLA-DRB1 shared epitope and smoking on the development of anti-citrullinated protein antibody positive rheumatoid arthritis in Greek patients

    Case-control study

  16. Rheumatology (Oxford)

    Elevated DAS28, CDAI, RAPID3 and five of seven RA core data set measures in patients with positive screens for anxiety, depression or fibromyalgia on an MDHAQ

    Cross-sectional study

  17. Ann Rheum Dis

    Minimally invasive retrieval and characterisation of tenosynovial tissue in rheumatoid arthritis: a novel approach to study at-risk, active, and remission stages

    Mechanistic study

  18. Arthritis Res Ther

    Predicting rheumatoid arthritis progression from seronegative undifferentiated arthritis using machine learning: a deep learning model trained on the KURAMA cohort and externally validated with the ANSWER cohort

    Diagnostic or prognostic study

  19. Rheumatology (Oxford)

    Ozoralizumab shows effectiveness regardless of baseline RF and ACPA titres in patients with RA: a post hoc analysis of the OHZORA trial

    Secondary analysis

  20. Clin Exp Rheumatol

    COVID-19 in rheumatoid arthritis: prevalence, hospital admission, and risk of all-cause mortality before and after COVID-19 pandemic

    Cohort study

  21. Scand J Rheumatol

    Sex differences in treatment response in patients with rheumatoid arthritis treated with tumour necrosis factor inhibitor: a cohort study from the DANBIO registry

    Cohort study

  22. Rheumatology (Oxford)

    Sustained efficacy of second-line JAK inhibitors in patients with rheumatoid arthritis: insights from the ANSWER cohort

    Cohort study

  23. Rheumatology (Oxford)

    Genetically-determined variation in CRP impacts disease activity assessment in rheumatoid arthritis

    Cohort study

  24. RMD Open

    Infliximab use and cervical spine deformity in patients with rheumatoid arthritis

    Case-control study

  25. Rheumatology (Oxford)

    Do MRI-detected erosions in the RA-risk phase of arthralgia reflect current or imminent radiographic erosions? A large longitudinal imaging study

    Cohort study

  26. Arthritis Rheumatol

    Genome‐Wide Aggregated Trans Effects Analysis Identifies Genes Encoding Immune Checkpoints as Core Genes for Rheumatoid Arthritis

    Research article

  27. Semin Arthritis Rheum

    Polygenic risk scores for rheumatoid arthritis and idiopathic pulmonary fibrosis and associations with RA, interstitial lung abnormalities, and quantitative interstitial abnormalities among smokers

    Cohort study

  28. Semin Arthritis Rheum

    Real-world evidence of the antifibrotic nintedanib in rheumatoid arthritis-interstitial lung disease. National multicenter study of 74 patients

    Cohort study

  29. Arthritis Rheumatol

    Cytotoxic Response of CD4 + T Cells Orchestrated by SLAMF4 in Rheumatoid Arthritis

    Mechanistic study

  30. Arthritis Res Ther

    Comparative effectiveness of subcutaneous sarilumab 200 mg biweekly, subcutaneous Tocilizumab 162 mg biweekly, and intravenous Tocilizumab 8 mg/kg every 4 weeks in patients with rheumatoid arthritis: a prospective cohort study

    Cohort study

  31. RMD Open

    Major adverse cardiovascular, thromboembolic and malignancy events in the filgotinib rheumatoid arthritis and ulcerative colitis clinical development programmes

    Research article

  32. Clin Exp Rheumatol

    Tofacitinib attenuates IL-6-mediated endothelial tissue factor induction in vitro without affecting platelet aggregation in vivo: mechanistic insights into cardiovascular risk in rheumatoid arthritis

    Mechanistic study

  33. J Rheumatol

    Sex Differences in Rheumatoid Arthritis: New Insights From Clinical and Patient-Reported Outcome Perspectives

    Secondary analysis

  34. J Rheumatol

    Healthcare Utilization and Cost of Herpes Zoster Infection in Patients With Rheumatoid Arthritis: A Retrospective Cohort Study

    Cohort study

  35. J Rheumatol

    Development of an Application for Self-Monitoring to Empower Patients With Rheumatoid Arthritis (MyRA)

    Research article

  36. RMD Open

    EducAR: implementing a multicomponent strategy to improve therapeutic adherence in rheumatoid arthritis

    Randomized controlled trial

  37. Scand J Rheumatol

    Early diagnosis of rheumatoid arthritis: associations between patients’ perceptions of initial symptoms and the timing of seeking help from the general practitioner

    Cross-sectional study

  38. RMD Open

    Lung ultrasound outperforms symptom-based screening to detect interstitial lung disease associated with rheumatoid arthritis

    Diagnostic or prognostic study

  39. Scand J Rheumatol

    Development and validation of a patient knowledge questionnaire for rheumatoid arthritis (PKQ-RA-11) in Danish and German

    Diagnostic or prognostic study

  40. Arthritis Care Res (Hoboken)

    Pregnancy Outcomes of Targeted Synthetic Disease‐Modifying Antirheumatic Drugs Among Patients With Autoimmune Diseases: A Scoping Review

    Research article

All 1,564 Briefs in ExploreShowing Briefs 561–600 of 1,564, newest first